 | • レポートコード：QYR2104Z0973 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脳疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（脳腫瘍、アルツハイマー病、アルコール依存症、健忘症、てんかん、髄膜炎、その他）、用途別市場規模（病院薬局、オンライン薬局、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳疾患の市場動向 ・企業の競争状況、市場シェア ・脳疾患の種類別市場規模（脳腫瘍、アルツハイマー病、アルコール依存症、健忘症、てんかん、髄膜炎、その他） ・脳疾患の用途別市場規模（病院薬局、オンライン薬局、薬局） ・脳疾患の北米市場規模2016-2027（アメリカ、カナダ） ・脳疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳疾患の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eli Lilly、F. Hoffmann La Roche、GE Healthcare、Janssen Pharmaceuticals、Abbvie、AC Immune、Allergan、Merck、Novartis、AstraZeneca） ・結論 |
Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer’s, Huntington’s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others. The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
Market Analysis and Insights: Global Brain Disease Market
The global Brain Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brain Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brain Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brain Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brain Disease market.
Global Brain Disease Scope and Market Size
Brain Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brain Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others
Segment by Application
Hospitals Pharmacy
Online Pharmacy
Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Brain Cancer
1.2.3 Alzheimer Disease
1.2.4 Alcoholism
1.2.5 Amnesia
1.2.6 Epilepsy
1.2.7 Meningitis
1.2.8 Others
1.3 Market by Application
1.3.1 Global Brain Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals Pharmacy
1.3.3 Online Pharmacy
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Brain Disease Market Perspective (2016-2027)
2.2 Brain Disease Growth Trends by Regions
2.2.1 Brain Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Brain Disease Historic Market Share by Regions (2016-2021)
2.2.3 Brain Disease Forecasted Market Size by Regions (2022-2027)
2.3 Brain Disease Industry Dynamic
2.3.1 Brain Disease Market Trends
2.3.2 Brain Disease Market Drivers
2.3.3 Brain Disease Market Challenges
2.3.4 Brain Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Disease Players by Revenue
3.1.1 Global Top Brain Disease Players by Revenue (2016-2021)
3.1.2 Global Brain Disease Revenue Market Share by Players (2016-2021)
3.2 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Brain Disease Revenue
3.4 Global Brain Disease Market Concentration Ratio
3.4.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2020
3.5 Brain Disease Key Players Head office and Area Served
3.6 Key Players Brain Disease Product Solution and Service
3.7 Date of Enter into Brain Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Disease Breakdown Data by Type
4.1 Global Brain Disease Historic Market Size by Type (2016-2021)
4.2 Global Brain Disease Forecasted Market Size by Type (2022-2027)
5 Brain Disease Breakdown Data by Application
5.1 Global Brain Disease Historic Market Size by Application (2016-2021)
5.2 Global Brain Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Brain Disease Market Size (2016-2027)
6.2 North America Brain Disease Market Size by Type
6.2.1 North America Brain Disease Market Size by Type (2016-2021)
6.2.2 North America Brain Disease Market Size by Type (2022-2027)
6.2.3 North America Brain Disease Market Size by Type (2016-2027)
6.3 North America Brain Disease Market Size by Application
6.3.1 North America Brain Disease Market Size by Application (2016-2021)
6.3.2 North America Brain Disease Market Size by Application (2022-2027)
6.3.3 North America Brain Disease Market Size by Application (2016-2027)
6.4 North America Brain Disease Market Size by Country
6.4.1 North America Brain Disease Market Size by Country (2016-2021)
6.4.2 North America Brain Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Brain Disease Market Size (2016-2027)
7.2 Europe Brain Disease Market Size by Type
7.2.1 Europe Brain Disease Market Size by Type (2016-2021)
7.2.2 Europe Brain Disease Market Size by Type (2022-2027)
7.2.3 Europe Brain Disease Market Size by Type (2016-2027)
7.3 Europe Brain Disease Market Size by Application
7.3.1 Europe Brain Disease Market Size by Application (2016-2021)
7.3.2 Europe Brain Disease Market Size by Application (2022-2027)
7.3.3 Europe Brain Disease Market Size by Application (2016-2027)
7.4 Europe Brain Disease Market Size by Country
7.4.1 Europe Brain Disease Market Size by Country (2016-2021)
7.4.2 Europe Brain Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Brain Disease Market Size (2016-2027)
8.2 Asia-Pacific Brain Disease Market Size by Type
8.2.1 Asia-Pacific Brain Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Brain Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Brain Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Brain Disease Market Size by Application
8.3.1 Asia-Pacific Brain Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Brain Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Brain Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Brain Disease Market Size by Region
8.4.1 Asia-Pacific Brain Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Brain Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Brain Disease Market Size (2016-2027)
9.2 Latin America Brain Disease Market Size by Type
9.2.1 Latin America Brain Disease Market Size by Type (2016-2021)
9.2.2 Latin America Brain Disease Market Size by Type (2022-2027)
9.2.3 Latin America Brain Disease Market Size by Type (2016-2027)
9.3 Latin America Brain Disease Market Size by Application
9.3.1 Latin America Brain Disease Market Size by Application (2016-2021)
9.3.2 Latin America Brain Disease Market Size by Application (2022-2027)
9.3.3 Latin America Brain Disease Market Size by Application (2016-2027)
9.4 Latin America Brain Disease Market Size by Country
9.4.1 Latin America Brain Disease Market Size by Country (2016-2021)
9.4.2 Latin America Brain Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Disease Market Size (2016-2027)
10.2 Middle East & Africa Brain Disease Market Size by Type
10.2.1 Middle East & Africa Brain Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Brain Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Brain Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Brain Disease Market Size by Application
10.3.1 Middle East & Africa Brain Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Brain Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Brain Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Brain Disease Market Size by Country
10.4.1 Middle East & Africa Brain Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Brain Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Brain Disease Introduction
11.1.4 Pfizer Revenue in Brain Disease Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Brain Disease Introduction
11.2.4 Eli Lilly Revenue in Brain Disease Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 F. Hoffmann La Roche
11.3.1 F. Hoffmann La Roche Company Details
11.3.2 F. Hoffmann La Roche Business Overview
11.3.3 F. Hoffmann La Roche Brain Disease Introduction
11.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2016-2021)
11.3.5 F. Hoffmann La Roche Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Brain Disease Introduction
11.4.4 GE Healthcare Revenue in Brain Disease Business (2016-2021)
11.4.5 GE Healthcare Recent Development
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Details
11.5.2 Janssen Pharmaceuticals Business Overview
11.5.3 Janssen Pharmaceuticals Brain Disease Introduction
11.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2016-2021)
11.5.5 Janssen Pharmaceuticals Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Brain Disease Introduction
11.6.4 Abbvie Revenue in Brain Disease Business (2016-2021)
11.6.5 Abbvie Recent Development
11.7 AC Immune
11.7.1 AC Immune Company Details
11.7.2 AC Immune Business Overview
11.7.3 AC Immune Brain Disease Introduction
11.7.4 AC Immune Revenue in Brain Disease Business (2016-2021)
11.7.5 AC Immune Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Brain Disease Introduction
11.8.4 Allergan Revenue in Brain Disease Business (2016-2021)
11.8.5 Allergan Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Brain Disease Introduction
11.9.4 Merck Revenue in Brain Disease Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Brain Disease Introduction
11.10.4 Novartis Revenue in Brain Disease Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Brain Disease Introduction
11.11.4 AstraZeneca Revenue in Brain Disease Business (2016-2021)
11.11.5 AstraZeneca Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Brain Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Brain Cancer
Table 3. Key Players of Alzheimer Disease
Table 4. Key Players of Alcoholism
Table 5. Key Players of Amnesia
Table 6. Key Players of Epilepsy
Table 7. Key Players of Meningitis
Table 8. Key Players of Others
Table 9. Global Brain Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Brain Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Brain Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Brain Disease Market Share by Regions (2016-2021)
Table 13. Global Brain Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Brain Disease Market Share by Regions (2022-2027)
Table 15. Brain Disease Market Trends
Table 16. Brain Disease Market Drivers
Table 17. Brain Disease Market Challenges
Table 18. Brain Disease Market Restraints
Table 19. Global Brain Disease Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Brain Disease Market Share by Players (2016-2021)
Table 21. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Disease as of 2020)
Table 22. Ranking of Global Top Brain Disease Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Brain Disease Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Brain Disease Product Solution and Service
Table 26. Date of Enter into Brain Disease Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Brain Disease Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Brain Disease Revenue Market Share by Type (2016-2021)
Table 30. Global Brain Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Brain Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Brain Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Brain Disease Revenue Market Share by Application (2016-2021)
Table 34. Global Brain Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Brain Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Brain Disease Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Brain Disease Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Brain Disease Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Brain Disease Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Brain Disease Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Brain Disease Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Brain Disease Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Brain Disease Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Brain Disease Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Brain Disease Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Brain Disease Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Brain Disease Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Brain Disease Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Brain Disease Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Brain Disease Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Brain Disease Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Brain Disease Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Brain Disease Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Brain Disease Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Brain Disease Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Brain Disease Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Brain Disease Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Brain Disease Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Brain Disease Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Brain Disease Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Brain Disease Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Brain Disease Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Brain Disease Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Brain Disease Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Brain Disease Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Brain Disease Product
Table 69. Pfizer Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Brain Disease Product
Table 74. Eli Lilly Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. F. Hoffmann La Roche Company Details
Table 77. F. Hoffmann La Roche Business Overview
Table 78. F. Hoffmann La Roche Brain Disease Product
Table 79. F. Hoffmann La Roche Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 80. F. Hoffmann La Roche Recent Development
Table 81. GE Healthcare Company Details
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Brain Disease Product
Table 84. GE Healthcare Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 85. GE Healthcare Recent Development
Table 86. Janssen Pharmaceuticals Company Details
Table 87. Janssen Pharmaceuticals Business Overview
Table 88. Janssen Pharmaceuticals Brain Disease Product
Table 89. Janssen Pharmaceuticals Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 90. Janssen Pharmaceuticals Recent Development
Table 91. Abbvie Company Details
Table 92. Abbvie Business Overview
Table 93. Abbvie Brain Disease Product
Table 94. Abbvie Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 95. Abbvie Recent Development
Table 96. AC Immune Company Details
Table 97. AC Immune Business Overview
Table 98. AC Immune Brain Disease Product
Table 99. AC Immune Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 100. AC Immune Recent Development
Table 101. Allergan Company Details
Table 102. Allergan Business Overview
Table 103. Allergan Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 104. Allergan Recent Development
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Brain Disease Product
Table 108. Merck Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 109. Merck Recent Development
Table 110. Novartis Company Details
Table 111. Novartis Business Overview
Table 112. Novartis Brain Disease Product
Table 113. Novartis Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 114. Novartis Recent Development
Table 115. AstraZeneca Company Details
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca Brain Disease Product
Table 118. AstraZeneca Revenue in Brain Disease Business (2016-2021) & (US$ Million)
Table 119. AstraZeneca Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Disease Market Share by Type: 2020 VS 2027
Figure 2. Brain Cancer Features
Figure 3. Alzheimer Disease Features
Figure 4. Alcoholism Features
Figure 5. Amnesia Features
Figure 6. Epilepsy Features
Figure 7. Meningitis Features
Figure 8. Others Features
Figure 9. Global Brain Disease Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Pharmacy Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Pharmacy Case Studies
Figure 13. Brain Disease Report Years Considered
Figure 14. Global Brain Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Brain Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Brain Disease Market Share by Regions: 2020 VS 2027
Figure 17. Global Brain Disease Market Share by Regions (2022-2027)
Figure 18. Global Brain Disease Market Share by Players in 2020
Figure 19. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Disease as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Brain Disease Revenue in 2020
Figure 21. Global Brain Disease Revenue Market Share by Type (2016-2021)
Figure 22. Global Brain Disease Revenue Market Share by Type (2022-2027)
Figure 23. North America Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Brain Disease Market Share by Type (2016-2027)
Figure 25. North America Brain Disease Market Share by Application (2016-2027)
Figure 26. North America Brain Disease Market Share by Country (2016-2027)
Figure 27. United States Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Brain Disease Market Share by Type (2016-2027)
Figure 31. Europe Brain Disease Market Share by Application (2016-2027)
Figure 32. Europe Brain Disease Market Share by Country (2016-2027)
Figure 33. Germany Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Brain Disease Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Brain Disease Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Brain Disease Market Share by Region (2016-2027)
Figure 43. China Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Brain Disease Market Share by Type (2016-2027)
Figure 51. Latin America Brain Disease Market Share by Application (2016-2027)
Figure 52. Latin America Brain Disease Market Share by Country (2016-2027)
Figure 53. Mexico Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Brain Disease Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Brain Disease Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Brain Disease Market Share by Country (2016-2027)
Figure 59. Turkey Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Brain Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Pfizer Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 64. F. Hoffmann La Roche Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 65. GE Healthcare Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 66. Janssen Pharmaceuticals Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 67. Abbvie Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 68. AC Immune Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 69. Allergan Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 71. Novartis Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 72. AstraZeneca Revenue Growth Rate in Brain Disease Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). …- 世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） The diagnosis of alzheimer's disease is divided into three steps. The first step is to determine whether it is alzheimer's disease.The second step is to look for the cause, to look for biomarkers such as prolapidin-1, prolapidin-2 and the amyloid gene, amyloid deposition, or hippocampal volume or me…
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2…
- 世界のアルツハイマー病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のアルツハイマー病診断市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …